Pricing Log in Create free account
Saturday 17 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.71 0.86 −1.42%
Market cap
$123.7B
P/E
13.2×
Fwd P/E
11.2×
Dividend yield
4.22%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bristol Myers Squibb Company (BMY) Shares outstanding

Alert me on Shares outstanding

Bristol Myers Squibb Company's shares outstanding at the end of fiscal 2025 was $2.0B, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $2.0B. Over the past ten years it has ranged from $1.6B (fiscal 2018) to $2.3B (fiscal 2020); the current reading is higher than 64% of that period. Bristol Myers Squibb Company ranks 6th of 20 Drug Manufacturers General companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $2.0B 0.59%
FY2024 $2.0B (2.45%)
FY2023 $2.1B (3.17%)
FY2022 $2.1B (4.41%)
FY2021 $2.2B (0.58%)
FY2020 $2.3B 31.89%
FY2019 $1.7B 4.58%
FY2018 $1.6B (0.91%)
FY2017 $1.7B (1.67%)
FY2016 $1.7B 0.06%

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $2.0B 0.05%
Mar 2026 $2.0B 0.39%
Dec 2025 $2.0B 0.00%
Sep 2025 $2.0B 0.05%
42 more quarters

Against its own ten years

Low $1.6B High $2.3B
Ten-year median $2.0B
Current reading's percentile 64

Shares outstanding against peers

Company Shares outstanding
PFE Pfizer Inc. compare $5.7B
NVO Novo Nordisk A/S compare $4.4B
SNY Sanofi compare $2.4B
BMY Bristol Myers Squibb Company $2.0B
GSK GSK PLC Sponsored ADR compare $2.0B
NVS Novartis AG compare $1.9B
AZN AstraZeneca PLC compare $1.6B
GILD Gilead Sciences, Inc. compare $1.2B
AMGN Amgen Inc. compare $544.0M

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on BMY